UroGen Pharma Ltd. (URGN) NASDAQ

$8.27 -0.64 (-7.18%)

Market Cap: $202.20M

As of 08/11/22 01:24 PM EDT. Market open.

(URGN)

UroGen Pharma Ltd. (URGN) NASDAQ

$8.27 -0.64 (-7.18%)

Market Cap: $202.20M

As of 08/11/22 01:24 PM EDT. Market open.

Urogen Pharma Ltd. is a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases because patients deserve better options. UroGen has developed RTGelTM reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. UroGen's sustained ... read more

Urogen Pharma Ltd. is a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases because patients deserve better options. UroGen has developed RTGelTM reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. UroGen's sustained release technology is designed to enable longer exposure of the urinary tract tissue to medications, making local therapy a potentially more effective treatment option. UroGen's first commercial product, and investigational treatment UGN-102 (mitomycin) for intravesical solution for patients with low-grade non-muscle invasive bladder cancer, are designed to ablate tumors by non-surgical means. UroGen is headquartered in Princeton, NJ with operations in Israel. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Elizabeth Barrett
Full Time Employees
187
CEO Compensation (Base)
$610,200
CEO Compensation (Total)
$5.95M
URL
Address
Raanana, 9 Hataasiya St, 4365007.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Elizabeth Barrett
Full Time Employees
187
CEO Compensation (Base)
$610,200
CEO Compensation (Total)
$5.95M
Address
Raanana, 9 Hataasiya St, 4365007.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$8.42
Previous Close
$8.91
Days Range
$8.21 - $8.91
52 week range
$4.85 - $19.66
Volume
33,832
Avg. Volume (30 days)
55,837
Market Cap
$202.20M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
22,693,170
Open
$8.42
Previous Close
$8.91
Days Range
$8.21 - $8.91
52 week range
$4.85 - $19.66
Volume
33,832
Avg. Volume (30 days)
55,837
Market Cap
$202.20M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
22,693,170

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR UROGEN PHARMA LTD
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Schoenberg Mark Chief Medical Officer Apr 30, 2022 Sale $6.62 254 1,681 23,467 May 03, 2022, 05:19 PM
Smith Jason Drew General Counsel Jan 31, 2022 Sale $7.58 414 3,138 7,449 Feb 02, 2022, 04:35 PM
Henderson Molly Chief Financial Officer Jan 31, 2022 Sale $7.58 331 2,509 5,248 Feb 02, 2022, 04:34 PM
Schoenberg Mark Chief Medical Officer Jan 31, 2022 Sale $7.58 1,374 10,415 23,221 Feb 02, 2022, 04:33 PM
Barrett Elizabeth A. Chief Executive Officer Jan 31, 2022 Sale $7.58 8,195 62,118 308,358 Feb 02, 2022, 04:32 PM
Schoenberg Mark Chief Medical Officer Jan 26, 2022 Sale $8.09 111 898 22,095 Jan 28, 2022, 04:29 PM
Barrett Elizabeth A. Chief Executive Officer Jan 04, 2022 Sale $9.15 46,968 429,757 298,220 Jan 07, 2022, 08:38 AM
Smith Jason Drew General Counsel Nov 30, 2021 Sale $12.03 3,803 45,750 7,030 Dec 02, 2021, 01:16 PM
Henderson Molly Chief Financial Officer Nov 30, 2021 Sale $12.03 2,587 31,122 4,913 Dec 02, 2021, 01:15 PM
Schoenberg Mark Chief Medical Officer Nov 18, 2021 Buy $13.10 160 2,096 21,997 Nov 19, 2021, 03:05 PM
Schoenberg Mark Chief Medical Officer Nov 01, 2021 Sale $17.16 258 4,427 21,837 Nov 02, 2021, 03:45 PM
Schoenberg Mark Chief Medical Officer Oct 27, 2021 Sale $16.32 107 1,746 21,595 Oct 28, 2021, 02:04 PM
Schoenberg Mark Chief Medical Officer Aug 02, 2021 Sale $15.64 243 3,801 21,494 Aug 03, 2021, 07:07 PM
Schoenberg Mark Chief Medical Officer Jul 26, 2021 Sale $15.30 103 1,576 20,821 Jul 28, 2021, 09:11 AM
Belldegrun Arie Director Mar 26, 2021 Option Exercise $5.00 3,241 16,205 245,452 Jun 09, 2021, 01:47 PM
Nussbaum Ran Director Mar 25, 2021 Option Exercise $5.00 1,030 5,150 1,431,717 Jun 09, 2021, 01:46 PM
Nussbaum Ran Director Mar 25, 2021 Option Exercise $5.00 2,211 11,055 1,433,928 Jun 09, 2021, 01:42 PM
Barrett Elizabeth A. Chief Executive Officer May 19, 2021 Option Exercise $17.51 3,425 59,968 240,739 May 21, 2021, 01:44 PM
Henderson Molly Chief Financial Officer May 17, 2021 Buy $15.85 2,500 39,625 2,500 May 18, 2021, 11:36 AM
Smith Jason Drew General Counsel May 17, 2021 Buy $15.71 2,500 39,275 2,500 May 18, 2021, 11:35 AM
Schoenberg Mark Chief Medical Officer Apr 30, 2021 Sale $20.00 243 4,860 21,132 May 04, 2021, 01:58 PM
Schoenberg Mark Chief Medical Officer Apr 26, 2021 Sale $19.63 89 1,747 20,875 Apr 27, 2021, 01:44 PM
Belldegrun Arie Director Mar 24, 2021 Option Exercise $5.00 3,241 16,205 245,452 Apr 22, 2021, 05:19 PM
Nussbaum Ran Director Mar 24, 2021 Option Exercise $5.00 1,030 5,150 1,465,199 Apr 22, 2021, 05:18 PM
Schoenberg Mark Chief Medical Officer Jan 31, 2021 Sale $22.07 1,076 23,747 20,755 Feb 02, 2021, 02:53 PM
Schoenberg Mark Chief Medical Officer Jan 26, 2021 Sale $22.12 100 2,212 19,831 Jan 26, 2021, 05:20 PM
Barrett Elizabeth A. Chief Executive Officer Dec 14, 2020 Buy $18.50 10,000 185,000 229,117 Dec 15, 2020, 05:27 PM
Schoenberg Mark Chief Medical Officer Dec 04, 2020 Sale $19.85 662 13,141 19,723 Dec 07, 2020, 03:59 PM
Schoenberg Mark Chief Medical Officer Oct 26, 2020 Sale $20.95 101 2,116 19,343 Oct 28, 2020, 02:12 PM
PFREUNDSCHUH PETER P. Chief Financial Officer Oct 15, 2020 Sale $21.77 2,400 52,248 11,829 Oct 16, 2020, 03:41 PM
Schoenberg Mark Chief Medical Officer Sep 04, 2020 Sale $20.20 348 7,030 19,236 Sep 08, 2020, 04:48 PM
PFREUNDSCHUH PETER P. Chief Financial Officer Sep 01, 2020 Sale $22.82 509 11,615 7,888 Sep 01, 2020, 02:37 PM
PFREUNDSCHUH PETER P. Chief Financial Officer Jul 27, 2020 Sale $23.51 141 3,315 7,355 Jul 28, 2020, 05:34 PM
Schoenberg Mark Chief Medical Officer Jul 27, 2020 Sale $23.51 70 1,646 18,543 Jul 28, 2020, 05:32 PM
Schoenberg Mark Chief Medical Officer Jun 04, 2020 Sale $27.51 349 9,602 18,404 Jun 05, 2020, 02:31 PM
PFREUNDSCHUH PETER P. Chief Financial Officer May 20, 2020 Sale $25.07 358 8,975 7,079 May 20, 2020, 04:44 PM
Schoenberg Mark Chief Medical Officer Apr 27, 2020 Sale $24.35 70 1,705 17,711 Apr 28, 2020, 01:53 PM
PFREUNDSCHUH PETER P. Chief Financial Officer Apr 27, 2020 Sale $24.35 141 3,433 6,396 Apr 28, 2020, 01:51 PM
Mullennix Stephen Chief Operating Officer Apr 27, 2020 Sale $24.35 145 3,531 10,084 Apr 28, 2020, 01:43 PM
Schoenberg Mark Chief Medical Officer Mar 04, 2020 Option Exercise $29.50 345 10,178 17,573 Mar 04, 2020, 05:28 PM
PFREUNDSCHUH PETER P. Chief Financial Officer Feb 20, 2020 Sale $29.68 360 10,685 6,120 Feb 24, 2020, 04:53 PM
Mullennix Stephen Chief Operating Officer Feb 14, 2020 Sale $28.04 612 17,160 9,812 Feb 18, 2020, 02:33 PM
PFREUNDSCHUH PETER P. Chief Financial Officer Jan 27, 2020 Sale $29.28 667 19,530 4,438 Jan 28, 2020, 05:15 PM
Mullennix Stephen Chief Operating Officer Jan 27, 2020 Sale $29.26 684 20,014 8,665 Jan 28, 2020, 05:14 PM
Schoenberg Mark Chief Medical Officer Jan 27, 2020 Sale $29.15 322 9,386 9,177 Jan 28, 2020, 05:10 PM
Schoenberg Mark Chief Medical Officer Dec 04, 2019 Option Exercise $31.69 343 10,870 8,666 Dec 05, 2019, 01:44 PM
Barrett Elizabeth A. Chief Executive Officer Nov 21, 2019 Buy $28.00 7,530 210,840 16,548 Nov 22, 2019, 03:34 PM
Barrett Elizabeth A. Chief Executive Officer Nov 20, 2019 Buy $28.00 7,470 209,160 9,018 Nov 22, 2019, 01:35 PM
PFREUNDSCHUH PETER P. Chief Financial Officer Nov 20, 2019 Sale $28.41 354 10,057 3,439 Nov 22, 2019, 01:29 PM
Schoenberg Mark Chief Medical Officer Nov 19, 2019 Buy $28.17 1,960 55,213 7,967 Nov 21, 2019, 08:49 PM
Barrett Elizabeth A. Chief Executive Officer Nov 15, 2019 Buy $26.00 1,548 40,248 1,548 Nov 18, 2019, 07:32 PM
Mullennix Stephen Chief Operating Officer Nov 14, 2019 Sale $26.00 608 15,806 7,683 Nov 18, 2019, 04:04 PM
Schoenberg Mark Chief Medical Officer Sep 04, 2019 Sale $33.92 343 11,635 6,007 Sep 06, 2019, 09:27 AM
PFREUNDSCHUH PETER P. Chief Financial Officer Aug 20, 2019 Sale $33.07 1,416 46,827 2,751 Aug 22, 2019, 01:31 PM
Mullennix Stephen Chief Operating Officer Aug 15, 2019 Sale $31.65 608 19,243 6,532 Aug 16, 2019, 03:38 PM
Schoenberg Mark Chief Medical Officer Jun 04, 2019 Option Exercise $35.05 343 12,022 5,309 Jun 06, 2019, 06:21 PM
Mullennix Stephen Chief Operating Officer May 14, 2019 Sale $37.98 608 23,092 5,381 May 16, 2019, 06:20 PM
Belldegrun Arie Director Mar 27, 2019 Option Exercise $4.02 128,000 514,560 212,211 Mar 28, 2019, 04:52 PM
Schoenberg Mark Chief Medical Officer Mar 21, 2019 Buy $37.01 272 10,066 4,610 Mar 22, 2019, 07:42 PM
Cohen Fred E Director Feb 06, 2019 Option Exercise $16.99 15,000 254,850 15,000 Mar 22, 2019, 07:41 PM
Schoenberg Mark Chief Medical Officer Mar 06, 2019 Sale $37.30 1,991 74,264 4,338 Mar 07, 2019, 09:46 PM
Mullennix Stephen Chief Operating Officer Feb 14, 2019 Sale $37.30 2,804 104,589 4,230 Mar 07, 2019, 09:44 PM
ProQuest Investments IV, L.P. 10% Owner Nov 28, 2017 Sale $40.51 177,807 7,202,961 1,242,031 Nov 29, 2017, 05:07 PM
ProQuest Investments IV, L.P. 10% Owner Nov 27, 2017 Sale $41.12 31,491 1,294,910 1,419,838 Nov 29, 2017, 05:07 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Schoenberg Mark Chief Medical Officer 04/30/2022 1,681
Smith Jason Drew General Counsel 01/31/2022 3,138
Henderson Molly Chief Financial Officer 01/31/2022 2,509
Schoenberg Mark Chief Medical Officer 01/31/2022 10,415
Barrett Elizabeth A. Chief Executive Officer 01/31/2022 62,118
Schoenberg Mark Chief Medical Officer 01/26/2022 898
Barrett Elizabeth A. Chief Executive Officer 01/04/2022 429,757
Smith Jason Drew General Counsel 11/30/2021 45,750
Henderson Molly Chief Financial Officer 11/30/2021 31,122
Schoenberg Mark Chief Medical Officer 11/18/2021 2,096
Schoenberg Mark Chief Medical Officer 11/01/2021 4,427
Schoenberg Mark Chief Medical Officer 10/27/2021 1,746
Schoenberg Mark Chief Medical Officer 08/02/2021 3,801
Schoenberg Mark Chief Medical Officer 07/26/2021 1,576
Belldegrun Arie Director 03/26/2021 16,205
Nussbaum Ran Director 03/25/2021 5,150
Nussbaum Ran Director 03/25/2021 11,055
Barrett Elizabeth A. Chief Executive Officer 05/19/2021 59,968
Henderson Molly Chief Financial Officer 05/17/2021 39,625
Smith Jason Drew General Counsel 05/17/2021 39,275
Schoenberg Mark Chief Medical Officer 04/30/2021 4,860
Schoenberg Mark Chief Medical Officer 04/26/2021 1,747
Belldegrun Arie Director 03/24/2021 16,205
Nussbaum Ran Director 03/24/2021 5,150
Schoenberg Mark Chief Medical Officer 01/31/2021 23,747
Schoenberg Mark Chief Medical Officer 01/26/2021 2,212
Barrett Elizabeth A. Chief Executive Officer 12/14/2020 185,000
Schoenberg Mark Chief Medical Officer 12/04/2020 13,141
Schoenberg Mark Chief Medical Officer 10/26/2020 2,116
PFREUNDSCHUH PETER P. Chief Financial Officer 10/15/2020 52,248
Schoenberg Mark Chief Medical Officer 09/04/2020 7,030
PFREUNDSCHUH PETER P. Chief Financial Officer 09/01/2020 11,615
PFREUNDSCHUH PETER P. Chief Financial Officer 07/27/2020 3,315
Schoenberg Mark Chief Medical Officer 07/27/2020 1,646
Schoenberg Mark Chief Medical Officer 06/04/2020 9,602
PFREUNDSCHUH PETER P. Chief Financial Officer 05/20/2020 8,975
Schoenberg Mark Chief Medical Officer 04/27/2020 1,705
PFREUNDSCHUH PETER P. Chief Financial Officer 04/27/2020 3,433
Mullennix Stephen Chief Operating Officer 04/27/2020 3,531
Schoenberg Mark Chief Medical Officer 03/04/2020 10,178
PFREUNDSCHUH PETER P. Chief Financial Officer 02/20/2020 10,685
Mullennix Stephen Chief Operating Officer 02/14/2020 17,160
PFREUNDSCHUH PETER P. Chief Financial Officer 01/27/2020 19,530
Mullennix Stephen Chief Operating Officer 01/27/2020 20,014
Schoenberg Mark Chief Medical Officer 01/27/2020 9,386
Schoenberg Mark Chief Medical Officer 12/04/2019 10,870
Barrett Elizabeth A. Chief Executive Officer 11/21/2019 210,840
Barrett Elizabeth A. Chief Executive Officer 11/20/2019 209,160
PFREUNDSCHUH PETER P. Chief Financial Officer 11/20/2019 10,057
Schoenberg Mark Chief Medical Officer 11/19/2019 55,213
Barrett Elizabeth A. Chief Executive Officer 11/15/2019 40,248
Mullennix Stephen Chief Operating Officer 11/14/2019 15,806
Schoenberg Mark Chief Medical Officer 09/04/2019 11,635
PFREUNDSCHUH PETER P. Chief Financial Officer 08/20/2019 46,827
Mullennix Stephen Chief Operating Officer 08/15/2019 19,243
Schoenberg Mark Chief Medical Officer 06/04/2019 12,022
Mullennix Stephen Chief Operating Officer 05/14/2019 23,092
Belldegrun Arie Director 03/27/2019 514,560
Schoenberg Mark Chief Medical Officer 03/21/2019 10,066
Cohen Fred E Director 02/06/2019 254,850
Schoenberg Mark Chief Medical Officer 03/06/2019 74,264
Mullennix Stephen Chief Operating Officer 02/14/2019 104,589
ProQuest Investments IV, L.P. 10% Owner 11/28/2017 7,202,961
ProQuest Investments IV, L.P. 10% Owner 11/27/2017 1,294,910
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2022
12/31/2021
1.27%
1Q
03/31/2022
09/30/2021
1.40%
2Q
03/31/2022
06/30/2021
1.55%
3Q
03/31/2022
03/31/2021
1.75%
4Q
03/31/2022
12/31/2020
3.91%
5Q
03/31/2022
09/30/2020
4.50%
6Q
03/31/2022
06/30/2020
5.49%
7Q
03/31/2022
03/31/2020
6.96%
8Q
03/31/2022
12/31/2019
10.24%
9Q
03/31/2022
09/30/2019
11.09%
10Q
03/31/2022
06/30/2019
12.62%
11Q
03/31/2022
03/31/2019
17.02%
12Q
03/31/2022
12/31/2018
43.65%
13Q
Load More

Period of Report: 03/31/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2021
1.27%
1Q
09/30/2021
1.40%
2Q
06/30/2021
1.55%
3Q
03/31/2021
1.75%
4Q
12/31/2020
3.91%
5Q
09/30/2020
4.50%
6Q
06/30/2020
5.49%
7Q
03/31/2020
6.96%
8Q
12/31/2019
10.24%
9Q
09/30/2019
11.09%
10Q
06/30/2019
12.62%
11Q
03/31/2019
17.02%
12Q
12/31/2018
43.65%
13Q
Load More